Balyasny Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $440K | Sell |
|
|||||
|
2024
Q4 | $18.3M | Sell |
|
|||||
|
2024
Q3 | $41.2M | Sell |
|
|||||
|
2024
Q2 | $60.8M | Buy |
|
|||||
|
2024
Q1 | $44.1M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $5.71M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $16.7M | Buy |
|
|||||
|
2022
Q4 | $16.4M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $19.8M | Buy |
|
|||||
|
2022
Q1 | $8.48M | Buy |
|
|||||
|
2021
Q4 | $158K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $25M | Buy |
|
|||||
|
2018
Q4 | $12.1M | Sell |
|
|||||
|
2018
Q3 | $35M | Buy |
|
|||||
|
2018
Q2 | $23.2M | Sell |
|
|||||
|
2018
Q1 | $27M | Buy |
|
|||||
|
2017
Q4 | $10.5M | Sell |
|
|||||
|
2017
Q3 | $29M | Buy |
|
|||||
|
2017
Q2 | – | Hold |
|
|||||
|
2017
Q1 | – | Hold |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $6.2M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $10.5M | Sell |
|
|||||
|
2015
Q4 | $223M | Buy |
|
|||||
|
2015
Q3 | $72.2M | Sell |
|
|||||
|
2015
Q2 | $79.3M | Buy |
|
|||||
|
2015
Q1 | $3.97M | Sell |
|
|||||
|
2014
Q4 | $40.1M | Buy |
|
|||||
|
2014
Q3 | $9.39M | Sell |
|
|||||
|
2014
Q2 | $20.5M | Buy |
|
|||||
|
2014
Q1 | $15.1M | Buy |
|
|||||
|
2013
Q4 | $5.63M | Sell |
|
|||||
|
2013
Q3 | $23.3M | Sell |
|
|||||
|
2013
Q2 | $31.5M | Buy |
|